Impact of Amiodarone Therapy on the Ablation Outcome of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Cardiomyopathy

(1) Background: Catheter ablation (CA) is an accepted treatment option for drug-refractory ventricular tachycardia (VT) in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC). This study investigates the effect of amiodarone on ablation outcomes in ARVC. (2) Methods: The study enrol...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Chin-Yu, Chung, Fa-Po, Nwe, Nwe, Hsieh, Yu-Cheng, Li, Cheng-Hung, Lin, Yenn-Jiang, Chang, Shih-Lin, Lo, Li-Wei, Hu, Yu-Feng, Tuan, Ta-Chuan, Chao, Tze-Fan, Liao, Jo-Nan, Chang, Ting-Yung, Kuo, Ling, Wu, Cheng-I, Liu, Chih-Min, Liu, Shin-Huei, Cheng, Wen-Han, Chen, Shih-Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787968/
https://www.ncbi.nlm.nih.gov/pubmed/36555882
http://dx.doi.org/10.3390/jcm11247265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787968/
https://www.ncbi.nlm.nih.gov/pubmed/36555882
http://dx.doi.org/10.3390/jcm11247265

Ejemplares similares